MICROSATELLITE INSTABILITY HIGH CANCER
Clinical trials for MICROSATELLITE INSTABILITY HIGH CANCER explained in plain language.
Never miss a new study
Get alerted when new MICROSATELLITE INSTABILITY HIGH CANCER trials appear
Sign up with your email to follow new studies for MICROSATELLITE INSTABILITY HIGH CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kidney transplant patients with cancer: drug combo aims to fight tumors without losing the donated kidney
Disease control OngoingThis early-stage study tests whether a mix of three drugs—tacrolimus, nivolumab, and ipilimumab—can shrink or control certain skin cancers in people who have had a kidney transplant. The main goal is to see if the cancer responds without causing the body to reject the transplante…
Matched conditions: MICROSATELLITE INSTABILITY HIGH CANCER
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug XmAb20717 tested in rare cancers – trial suspended
Disease control TerminatedThis phase II trial tests the safety and effectiveness of a drug called XmAb20717 in 140 people with advanced rare cancers, including mesothelioma, lymphoma, and small cell lung cancer. The drug is given by IV. The main goal is to see if tumors shrink. The trial is currently susp…
Matched conditions: MICROSATELLITE INSTABILITY HIGH CANCER
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC